nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.0692	0.0692	CcSEcCtD
Gadodiamide—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.0423	0.0423	CcSEcCtD
Gadodiamide—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0372	0.0372	CcSEcCtD
Gadodiamide—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.0369	0.0369	CcSEcCtD
Gadodiamide—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.0305	0.0305	CcSEcCtD
Gadodiamide—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.0297	0.0297	CcSEcCtD
Gadodiamide—Melaena—Riluzole—amyotrophic lateral sclerosis	0.0292	0.0292	CcSEcCtD
Gadodiamide—Coma—Riluzole—amyotrophic lateral sclerosis	0.0273	0.0273	CcSEcCtD
Gadodiamide—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.0252	0.0252	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.0224	0.0224	CcSEcCtD
Gadodiamide—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.0223	0.0223	CcSEcCtD
Gadodiamide—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0218	0.0218	CcSEcCtD
Gadodiamide—Migraine—Riluzole—amyotrophic lateral sclerosis	0.0214	0.0214	CcSEcCtD
Gadodiamide—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.0204	0.0204	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.0165	0.0165	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.0164	0.0164	CcSEcCtD
Gadodiamide—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.0164	0.0164	CcSEcCtD
Gadodiamide—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0151	CcSEcCtD
Gadodiamide—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.015	0.015	CcSEcCtD
Gadodiamide—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0149	CcSEcCtD
Gadodiamide—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.0148	0.0148	CcSEcCtD
Gadodiamide—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.0147	0.0147	CcSEcCtD
Gadodiamide—Chills—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0135	CcSEcCtD
Gadodiamide—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.0134	0.0134	CcSEcCtD
Gadodiamide—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0128	CcSEcCtD
Gadodiamide—Tremor—Riluzole—amyotrophic lateral sclerosis	0.0123	0.0123	CcSEcCtD
Gadodiamide—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0121	CcSEcCtD
Gadodiamide—Malaise—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0118	CcSEcCtD
Gadodiamide—Syncope—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0117	CcSEcCtD
Gadodiamide—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0115	CcSEcCtD
Gadodiamide—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0113	CcSEcCtD
Gadodiamide—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0111	CcSEcCtD
Gadodiamide—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0111	CcSEcCtD
Gadodiamide—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0111	CcSEcCtD
Gadodiamide—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0111	CcSEcCtD
Gadodiamide—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.011	0.011	CcSEcCtD
Gadodiamide—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0109	CcSEcCtD
Gadodiamide—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0107	CcSEcCtD
Gadodiamide—Oedema—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0107	CcSEcCtD
Gadodiamide—Infection—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0106	CcSEcCtD
Gadodiamide—Shock—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0105	CcSEcCtD
Gadodiamide—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0105	CcSEcCtD
Gadodiamide—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0104	CcSEcCtD
Gadodiamide—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0103	CcSEcCtD
Gadodiamide—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00998	0.00998	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00973	0.00973	CcSEcCtD
Gadodiamide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00959	0.00959	CcSEcCtD
Gadodiamide—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00952	0.00952	CcSEcCtD
Gadodiamide—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00949	0.00949	CcSEcCtD
Gadodiamide—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.0094	0.0094	CcSEcCtD
Gadodiamide—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.0092	0.0092	CcSEcCtD
Gadodiamide—Pain—Riluzole—amyotrophic lateral sclerosis	0.00913	0.00913	CcSEcCtD
Gadodiamide—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.0088	0.0088	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00873	0.00873	CcSEcCtD
Gadodiamide—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00848	0.00848	CcSEcCtD
Gadodiamide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00844	0.00844	CcSEcCtD
Gadodiamide—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00844	0.00844	CcSEcCtD
Gadodiamide—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00787	0.00787	CcSEcCtD
Gadodiamide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00766	0.00766	CcSEcCtD
Gadodiamide—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00755	0.00755	CcSEcCtD
Gadodiamide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.0073	0.0073	CcSEcCtD
Gadodiamide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00706	0.00706	CcSEcCtD
Gadodiamide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00679	0.00679	CcSEcCtD
Gadodiamide—Rash—Riluzole—amyotrophic lateral sclerosis	0.00673	0.00673	CcSEcCtD
Gadodiamide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00673	0.00673	CcSEcCtD
Gadodiamide—Headache—Riluzole—amyotrophic lateral sclerosis	0.00669	0.00669	CcSEcCtD
Gadodiamide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00634	0.00634	CcSEcCtD
